Altimmune, Inc. Share Price & Technical Analysis
ALT · $2.87 (-1.03%)
Healthcare / Biotechnology
$2.87
-1.03%
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was fou…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-3% return in Jun, -19% avg return in past 3 year Jun month.
2% return in 2026, -24% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 56% | -23% | -26% | -16% | 15% | -3% | – | – | – | – | – | – | 2% |
| 25 | -10% | 5% | -25% | 6% | 4% | -29% | -3% | 6% | 0% | 8% | 33% | -29% | -35% |
| 24 | -15% | 29% | -16% | -35% | 14% | -12% | -4% | 5% | -9% | 10% | 26% | -16% | -25% |
| 23 | -18% | -7% | -66% | 21% | -22% | -15% | -8% | -24% | 4% | -8% | 33% | 96% | -11% |
| 22 | -14% | -7% | -18% | -26% | 13% | 134% | 3% | 84% | -42% | -2% | -23% | 53% | 155% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$572.73M
P/E ratio
—
52W high
$7.73
52W low
$2.56
Volume
30,23,137
Beta
0.17
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Altimmune, Inc. share price today?
- Altimmune, Inc. (ALT) last traded around $2.87 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ALT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ALT. Download the app for real-time alerts.
- How can I analyze Altimmune, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.